Appili Therapeutics Inc. (APLI.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.86M |
| Enterprise Value | 14.75M |
| P/E Ratio | -0.44 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 7.61 |
| Price/Book Ratio | -0.11 |
| Enterprise/Revenue | 57.04 |
| Enterprise/EBITDA | -2.99 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -16.22 |
| Operating Margin | -21.17 |
AD
Management Effectiveness
| Return On Assets | -2.14 |
| Return On Equity | 0.26 |
Income Statement
| Revenue | 244,179 |
| Revenue/Share | 0 |
| Gross Profit | 236,095 |
| EBITDA | -6.53M |
| Net Income | -4.24M |
| Diluted EPS | -0.03 |
Balance Sheet
| Total Cash | 40,003 |
| Total Cash/Share | 0 |
| Total Debt | 12.94M |
| Total Debt/Equity | -0.75 |
| Current Ratio | 0.11 |
| Book Value Per Share | -0.13 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 0.04 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.02 |
Statistics
| Average Volume | 55,211 |
| Shares Outstanding | 132.37M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
